Canopy Growth (CGC) Total Liabilities (2017 - 2026)
Canopy Growth (CGC) reported Total Liabilities of $307.1 million for Q1 2026, little changed on a YoY basis from $306.0 million in Q1 2025, and up 19.27% sequentially from $257.5 million in Q4 2025.
Canopy Growth (CGC) Total Liabilities (2017 - 2026) Analysis & Trends
Canopy Growth (CGC) has 10 years of Total Liabilities data on file, last reported at $307.1 million in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities changed 0.34% year-over-year to $307.1 million; the trailing twelve-month figure through Mar 2026 stood at $307.1 million (changed 0.34% YoY), and the FY2026 full-year result was $307.1 million, changed 0.34% from the prior year.
- Total Liabilities improved to $307.1 million in Q1 2026, from $257.5 million in the prior quarter.
- In the past five years, Total Liabilities ranged from a high of $1.6 billion in Q1 2022 to a low of $253.7 million in Q3 2025.
- A 5-year average of $750.7 million and a median of $605.7 million in 2023 frame the typical range for Total Liabilities.
- Across the five-year window, Total Liabilities plunged 54.94% in 2025 and advanced 0.34% in 2026, its largest moves.
- Tracing CGC's Total Liabilities over 5 years: stood at $1.2 billion in 2022, then slumped by 47.99% to $605.7 million in 2023, then retreated by 28.35% to $434.0 million in 2024, then sank by 40.67% to $257.5 million in 2025, then climbed by 19.27% to $307.1 million in 2026.
- Business Quant data shows CGC's Total Liabilities at $307.1 million in Q1 2026, $257.5 million in Q4 2025, and $253.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.48 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 31.81 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 11.92 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 51.53 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 813.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 13.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 22.18 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 1.50 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.72 Bn |
| 10 | Canopy Growth | 197.77 Mn | -68.15 Mn | - | 307.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 307.10 Mn |
| Dec 31, 2025 | 257.47 Mn |
| Sep 30, 2025 | 253.70 Mn |
| Jun 30, 2025 | 308.66 Mn |
| Mar 31, 2025 | 306.04 Mn |
| Dec 31, 2024 | 433.96 Mn |
| Sep 30, 2024 | 563.01 Mn |
| Jun 30, 2024 | 598.88 Mn |
| Mar 31, 2024 | 667.73 Mn |
| Dec 31, 2023 | 605.71 Mn |
| Sep 30, 2023 | 700.74 Mn |
| Jun 30, 2023 | 999.82 Mn |
| Mar 31, 2023 | 1.24 Bn |
| Dec 31, 2022 | 1.16 Bn |
| Sep 30, 2022 | 1.35 Bn |
| Jun 30, 2022 | 1.44 Bn |
| Mar 31, 2022 | 1.57 Bn |
| Dec 31, 2021 | 1.66 Bn |
| Sep 30, 2021 | 1.73 Bn |
| Jun 30, 2021 | 2.19 Bn |